We demonstrate that polymorphisms genetically and structurally associated with human lncRAP2 are linked to metabolic diseases, but their impact on the expression or function of human lncRAP2/Igf2bp2 and their targets was not investigated. Here, IGF2BP2 is linked to metabolic disease.